Welcome to our dedicated page for Encompass Health news (Ticker: EHC), a resource for investors and traders seeking the latest updates and insights on Encompass Health stock.
Encompass Health Corporation reports developments tied to its role as an operator of inpatient rehabilitation hospitals in the United States. Company news commonly covers hospital openings and capacity additions, rehabilitative care for patients recovering from strokes, neurological disorders, brain and spinal cord injuries, amputations and complex orthopedic conditions, and updates from its national hospital network.
Recurring announcements also include quarterly operating results, same-store discharge trends, net patient revenue per discharge, cash dividends on common stock, investor conference participation and annual stockholder meeting matters. These updates connect Encompass Health's post-acute care model with its hospital expansion activity, patient-volume measures, reimbursement-sensitive revenue trends and public-company governance calendar.
Encompass Health (NYSE: EHC) will report first-quarter results for the period ended March 31, 2026, after market close on Thursday, April 30, 2026.
The company will host an investor conference call at 10:00 a.m. ET on Friday, May 1, 2026, accessible by phone (800-267-6316; conference ID EHCQ126) and via live webcast and replay on the company's investor website.
Encompass Health (NYSE:EHC) plans to build a freestanding 40-bed inpatient rehabilitation hospital in Bear, Delaware, serving patients recovering from strokes, neurological disorders, spinal cord and brain injuries, amputations and complex orthopedic conditions.
The facility will include private rooms, a therapy gym with advanced technologies, an activities-of-daily-living suite, in-house dialysis, dining, pharmacy and a therapy courtyard. It will be the company's second Delaware location, adding local access for New Castle County residents.
Encompass Health (NYSE:EHC) opened Encompass Health Rehabilitation Hospital of Irmo on March 3, 2026. The 49-bed, 53,000-square-foot freestanding facility is now accepting patients and provides inpatient rehabilitation for stroke, brain injury, spinal cord injury, amputation and complex orthopedic recovery.
The hospital offers a minimum of three hours of daily therapy five days per week, 24-hour nursing, frequent physician visits, an advanced therapy gym, dialysis suite, private rooms and an on-site pharmacy. This is Encompass Health's 11th location in South Carolina.
Encompass Health (NYSE: EHC) will participate in the Barclays Global Healthcare Conference March 10-12, 2026. A fireside chat with President & CEO Mark Tarr and EVP & CFO Doug Coltharp is scheduled for March 11, 2026, 9:00–9:25 a.m. ET.
The session will be broadcast live and available via the company's investor website at investor.encompasshealth.com.
Encompass Health (NYSE: EHC) was named to the Fortune 2026 World's Most Admired Companies list and the Forbes 2026 America's Best Companies list on Feb. 24, 2026.
The recognition marks the sixth consecutive year on Fortune's list and reflects strengths in patient care, corporate culture and long‑term performance, per the company.
Encompass Health (NYSE:EHC) announced a quarterly cash dividend of $0.19 per share. The dividend is payable on April 15, 2026 to shareholders of record as of April 1, 2026.
Encompass Health (NYSE: EHC) announced plans to build a freestanding 50-bed inpatient rehabilitation hospital in Flowood, Mississippi, expected to open in 2027. The facility will offer 24-hour nursing, physical, occupational and speech therapies, private rooms, a therapy gym with advanced technologies, an in-house dialysis suite and supportive amenities.
This will be Encompass Health's second Mississippi hospital, expanding access to specialized post-acute rehabilitation services for the Jackson area and central Mississippi.
Enhabit (NYSE:EHAB) and Encompass Health (NYSE:EHC) collected $43.1 million in full satisfaction of claims for attorneys’ fees and mitigation damages from individual defendants in the Delaware Court of Chancery.
The December 2024 judgment found breaches of the duty of loyalty by named former officers; the court also placed a constructive trust granting Enhabit and Encompass Health a split of 43% of VitalCaring Group’s ongoing profits and exit proceeds if VitalCaring is sold. The settlement proceeds will be divided substantially equally between Enhabit and Encompass Health.
Encompass Health (NYSE: EHC) reported strong Q4 2025 results and issued 2026 guidance. Q4 net operating revenue was $1,544.6M, up 9.9% versus Q4 2024. Adjusted EPS was $1.46 and Adjusted EBITDA was $335.6M. The company added 517 inpatient beds in 2025.
2026 guidance targets net operating revenue of $6,365–$6,465M, Adjusted EBITDA of $1,340–$1,380M, and adjusted EPS of $5.81–$6.10.
Encompass Health (NYSE: EHC) announced on February 2, 2026 the appointment of Cain A. Hayes to its board of directors.
Hayes retired as president and CEO of Point32Health in 2024 and previously led Gateway Health Plan and held senior roles at Aetna and Nationwide. Board chair Greg Carmichael highlighted Hayes' payor expertise and leadership as strengthening board succession and strategic oversight.